PWPancheng Wu

Pancheng Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pancheng Wu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Naixin Liang

    Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China

    1 shared publication
  • Yang Song

    Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China

    1 shared publication
  • Yanyu Wang

    Department of Thoracic Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China

    1 shared publication
  • Yijun Wu

    Peking Union Medical College, Eight-Year MD Program, Chinese Academy of Medical Sciences, Beijing, China

    1 shared publication
  • Ziqi Jia

    Peking Union Medical College, Eight-Year MD Program, Chinese Academy of Medical Sciences, Beijing, China

    1 shared publication

Latest Publications

  • Open Access

    Expression and prognostic analyses of ITGA11, ITGB4 and ITGB8 in human non-small cell lung cancer

    by Pancheng Wu, Yanyu Wang, Yijun Wu, Ziqi Jia, Yang Song, Naixin Liang

    Background: Integrins play a crucial role in the regulation process of cell proliferation, migration, differentiation, tumor invasion and metastasis. ITGA11, ITGB4 and ITGB8 are three encoding genes of integrins family. Accumulative evidences have proved that abnormal expression of ITGA11, ITGB4 and ITGB8 are a common phenomenon in different malignances. However, their expression patterns and prognostic roles for patients with non-small cell lung cancer (NSCLC) have not been completely illustrated. Methods: We investigated the expression patterns and prognostic values of ITGA11, ITGB4 and ITGB8 in patients with NSCLC through using a series of databases and various datasets, including ONCOMINE, GEPIA, HPA, TCGA and GEO datasets. Results: We found that the expression levels of ITGA11 and ITGB4 were significantly upregulated in both LUAD and LUSC, while ITGB8 was obviously upregulated in LUSC. Additionally, higher expression level of ITGB4 revealed a worse OS in LUAD. Conclusion: Our findings suggested that ITGA11 and ITGB4 might have the potential ability to act as diagnostic biomarkers for both LUAD and LUSC, while ITGB8 might serve as diagnostic biomarker for LUSC. Furthermore, ITGB4 could serve as a potential prognostic biomarker for LUAD.